About 141,000 results
Open links in new tab
Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced …
Twice-yearly shot proves successful at preventing HIV infection …
Gilead Agrees to Allow Generic Version of ... - The New York Times
Gileads Twice Yearly Lenacapavir Demonstrated 100 Efficacy and ...
Gilead Sciences, Inc. - Gilead Signs Royalty-Free Voluntary …
UNAIDS response to Gilead’s announcement on signing voluntary …
Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced …
Gilead Signs Royalty-Free Voluntary Licensing Agreements with …
Gilead agrees to license new HIV drug in low-income countries
Gilead Sciences, Inc. - Gilead’s Twice-Yearly Lenacapavir for HIV ...